Velocity Clinical Research

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)3 trials
• Obesity2 trials

Phase

• Phase 23 trials
• Phase 1/21 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Currax Pharmaceuticals1 trial
• Kowa Research Institute, Inc.1 trial
• Regeneron Pharmaceuticals1 trial
• Regor Pharmaceuticals Inc.1 trial
• Rivus Pharmaceuticals, Inc.1 trial

Running trials

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source

• Active, not recruiting

  Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

  NCT05979779· Phase 2· Rivus Pharmaceuticals, Inc.· Source

• Recruiting

  A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

  NCT05648214· Phase 1/2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting

Closed trials

• Completed

  A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

  NCT06277934· Phase 2· Regor Pharmaceuticals Inc.· Source

• Completed

  Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

  NCT05327127· Phase 2· Kowa Research Institute, Inc.· Source